Delivery Order SPE2DB20D1110-SPE2DB25FK34S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methyldopa 250 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $2,586.10. The order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,132.05 by the Defense Logistics Agency's Medical Supply Chain on June 3, 2025, for the supply of Methyldopa 250 mg tablets in quantities of 90. This competitively awarded, firm fixed-price contract carries an ultimate completion date of June 4, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 25, 2025, for the supply of Methyldopa 250 mg tablets (180 count) valued at $2,334.14. This firm fixed-price contract, which is due for completion by August 26, 2025, was awarded without a set-aside designation through competitive procedures. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the company's role...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methyldopa 250 mg tablets in a quantity of 90 units. This contract, valued at $4,355.48 and classified as a firm fixed price delivery order, is scheduled for completion by April 25, 2025. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.06 firm-fixed-price delivery order is for the supply of 4,568,250,671 units of the drug Methyldopa 250 mg Tablet, with a performance period extending through May 15, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,519,911 units of the drug Methyldopa 250 mg tablets in 90-count packages, with a total ceiling value of $4,502.52. The contract has an ultimate completion date of June 12, 2025 and was awarded on June 11, 2025. It is a firm fixed-price contract with no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,721.57 firm fixed-price delivery order is for the supply of 4,566,708,164 units of Methyldopa 250 mg tablets, with a period of performance through December 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVUHS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,145.47 delivery order contract is for the supply of 4,567,958,207 tablets of the medication Methyldopa 250 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp also holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methyldopa 250 mg tablets in quantities of 180s, with a ceiling value of $4,051.57 and a performance period through July 9, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This federal contract award, valued at $1,349.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,038,863 tablets of Methyldopa 250 mg, a medication used to treat high blood pressure. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor, and there...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK34SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methyldopa 500 mg tablets (180-count) with a ceiling value of $6,783.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 18, 2025, and represents a continuation of pharmaceutical supply services under the contractor's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's consistent success in competing for and fulfilling federal pharmaceutical requirements through open competition demonstrates its capability to meet stringent federal procurement standards and support the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/15/25 |